Skip to main content
 

AHA Innovators’ Network Member Accurkardia Publishes First Study Showcasing the Clinical Value of its AccurBeat Platform

AHA Innovators’ Network Member Accurkardia Publishes First Study Showcasing the Clinical Value of its AccurBeat Platform

AHA Innovators’ Network member AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the clinical value of its AccurBeat platform. AccurBeat is AccurKardia’s platform for analysis of 30-seconds ECGs generated by wearable devices. The full study, conducted in collaboration by HITLAB (Healthcare Innovation & Technology Lab) and SUNY Downstate at JMIR Publications.

Read more here

More News

  • AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0

  • Amplity joins Innovators’ Network at the American Heart Association’s Center for Health Technology & Innovation

  • MicroTransponder Announces Positive Medicare Payment Change for Vivistim® Procedure